Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Dry Cupping Therapy and Muscle Energy Technique on Upper Crossed Syndrome

17 juni 2026 bijgewerkt door: Abdelrahman Ahmed Tarek

Effect of Combined Dry Cupping Therapy and Muscle Energy Technique on Upper Crossed Syndrome Patients. A Randomized Control Study

This study evaluated and compared the therapeutic efficacy of combining Dry Cupping therapy with the Muscle Energy Technique (MET) against each intervention applied independently, focusing on three core parameters: Neck Disability Index (NDI), Craniovertebral Angle (CVA), and Sagittal Shoulder-C7 Angle (SSA).

Studie Overzicht

Gedetailleerde beschrijving

This study evaluated and compared the therapeutic efficacy of combining Dry Cupping therapy with the Muscle Energy Technique (MET) against each intervention applied independently, focusing on three core parameters: Neck Disability Index (NDI), Craniovertebral Angle (CVA), and Sagittal Shoulder-C7 Angle (SSA).

Methods: A pre-test post-test double-blinded randomized controlled trial design was employed. Seventy-six adults (aged 20-40 years) diagnosed with UCS were randomly allocated into four equal experimental groups (n = 19 per group): Group A received combined dry cupping and MET with conventional therapy; Group B received dry cupping with conventional therapy; Group C received MET with conventional therapy; and Group D received conventional therapy alone. Interventions were conducted over an 8-week period. Primary outcomes included functional impairment via the Arabic version of the NDI, and objective sagittal alignment parameters (CVA and SSA) measured using precision photometry via the Kinovea software application.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

76

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Giza, Egypte
        • Cairo University

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Participant inclusion was restricted to individuals between 20 and 40 years of age.
  • The exact diagnostic criteria required a baseline craniovertebral angle (CVA) of less than 48 degrees.
  • a sagittal shoulder-C7 angle (SSA) of less than 52 degrees.

Exclusion Criteria:

  • acute post-surgical conditions
  • structural spinal deformities (e.g., severe fixed structural scoliosis)
  • cervical radiculopathy, or localized dermal infections contradicting cupping application.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Group A (Combined group)
Group A (Combined group): This group of nineteen subjects received combined dry cupping therapy, Muscle energy techniques, and conventional physical therapy.

19 subjects received combined dry cupping therapy, Muscle energy technique, and conventional physical therapy for eight weeks.

  1. Dry cupping was applied to the regional hypertonic target sites. Standard plastic cups ranging from 25 to 50 mm were placed directly over each subject's levator scapulae trigger point (SI-14) and upper trapezius trigger point (GB-21) bilaterally. The treatment duration was set at exactly 8 minutes per session.
  2. Muscle Energy Technique The Post-Isometric Relaxation (PIR) manual protocol targeted the hypertonic muscles of the upper crossed syndrome quadrant, including the upper trapezius, levator scapulae, sternocleidomastoid, scalenes, and suboccipital groups. Participants were placed in a supine position on the treatment table with their head free from the edge of the plinth, supported by the physical therapist.
  3. conventional physical therapy treatment
Experimenteel: Group B (Cupping group)
Group B (Cupping group): This group of nineteen subjects received dry cupping therapy and conventional physical therapy.

19 subjects received combined dry cupping therapy and conventional physical therapy for eight weeks.

  1. Dry cupping was applied to the regional hypertonic target sites. Standard plastic cups ranging from 25 to 50 mm were placed directly over each subject's levator scapulae trigger point (SI-14) and upper trapezius trigger point (GB-21) bilaterally. The treatment duration was set at exactly 8 minutes per session.
  2. conventional physical therapy treatment
Experimenteel: Group C (MET group)
Group C (MET group): This group of nineteen subjects received Muscle energy techniques and conventional physical therapy.

19 subjects received combined Muscle energy technique, and conventional physical therapy for eight weeks.

  1. Muscle Energy Technique The Post-Isometric Relaxation (PIR) manual protocol targeted the hypertonic muscles of the upper crossed syndrome quadrant, including the upper trapezius, levator scapulae, sternocleidomastoid, scalenes, and suboccipital groups. Participants were placed in a supine position on the treatment table with their head free from the edge of the plinth, supported by the physical therapist.
  2. conventional physical therapy treatment
Actieve vergelijker: Group D (Control group)
Group D (Control group): This group of nineteen subjects received conventional physical therapy alone
19 subjects received only conventional physical therapy for eight weeks.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Neck Disability Index (NDI)
Tijdsspanne: At baseline and re assessed following 8 weeks
Perceived functional limitations resulting from regional impairment were measured using the validated Arabic version of the NDI questionnaire. This instrument evaluates 10 clinical sections (including activities of daily living, concentration, and pain profiles) scored from 0 to 5 per item, yielding a cumulative score out of 50. Higher aggregate indices represent greater functional disability.
At baseline and re assessed following 8 weeks
craniovertebral angle (CVA)
Tijdsspanne: At baseline and re assessed following 8 weeks
This biomechanical index reflects the architectural severity of forward head posture. It is defined as the angle formed between a horizontal line drawn through the spinous process of C7 and an intersecting line extending from the tragus of the ear to the C7 landmark. CVA was measured using precision digital photogrammetry via the Kinovea software application.
At baseline and re assessed following 8 weeks
Sagittal Shoulder-C7 Angle (SSA)
Tijdsspanne: At baseline and re assessed following 8 weeks
This geometric marker quantifies shoulder roundedness and anterior protraction. It is formed by the intersection of a horizontal reference line passing through the lateral aspect of the acromion with a line drawn from the C7 spinous process to the lateral acromion. SSA was measured using precision digital photogrammetry via the Kinovea software application.
At baseline and re assessed following 8 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 maart 2026

Primaire voltooiing (Geschat)

18 juni 2026

Studie voltooiing (Geschat)

30 juni 2026

Studieregistratiedata

Eerst ingediend

13 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

13 juni 2026

Eerst geplaatst (Werkelijk)

17 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

22 juni 2026

Laatste update ingediend die voldeed aan QC-criteria

17 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren